Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors

doi:10.5306/wjco.v14.i3.117

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5268)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

284

WORD

HTML

2718

Figures (1-3)

334

Tables (1-1)

287

Sum=3678

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

181

Download

645

Sum=826

Publishing Process of This Article

Item

Count

Browse

175

Download

589

Sum=764

Mar 24, 2023 (publication date) through Jan 18, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Mar 24, 2023; 14(3): 117-130
Published online Mar 24, 2023. doi: 10.5306/wjco.v14.i3.117

Full Size Figure Download Figure

Figure 1 Molecular subgroups of medulloblastoma based on 2021 World Health Organization classification of central nervous system tumours. SHH: Sonic-hedgehog; MYC: Myelocytomatosis oncogene; LCA: Life cycle assessment; WNT: Wingless.

Citation: Kurdi M, Mulla N, Malibary H, Bamaga AK, Fadul MM, Faizo E, Hakamy S, Baeesa S. Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors. World J Clin Oncol 2023; 14(3): 117-130
URL: https://www.wjgnet.com/2218-4333/full/v14/i3/117.htm
DOI: https://dx.doi.org/10.5306/wjco.v14.i3.117